Dark

VTYX
Ventyx Biosciences, Inc. Common Stock
stock NASDAQ

Inactive

Mar 3, 2026

14.00USD+0.143%(+0.02)5,448,871

Pre-market

0.00USD-100.000%(-13.98)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Headquarters

Encinitas, CA, USA

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Profile

we are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. ventyx now includes combined assets from three separate companies: oppilan pharma, targeting s1p1r, zomagen biosciences, targeting nlrp3 and the inflammasome, and ventyx biosciences, targeting tyk2.

.dark-mode .T1PTKD{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .T1PTKD{ color: #333333; background-color: white; border: 2px solid #333333; }VTYXVentyx Biosciences, Inc. Common Stockstock NASDAQ

VTYX
Ventyx Biosciences, Inc. Common Stock
stock NASDAQ